Major Chinese pharmaceutical firms trading in Hong Kong are set to report annual profits as drug sales climb and lucrative global partnerships take effect following substantial research investments. This financial turnaround positions the healthcare sector as an attractive area for fintech innovation, including blockchain-based supply chain solutions and digital health records management.